advertisement
Khan M 11
Showing records 1 to 11 | Display all abstracts from Khan M104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Khan M
Current Pharmaceutical Design 2022; 0:
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Khan M; Shah S
Ocular Immunology and Inflammation 2022; 0: 1-11
104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Halim SA; Shafiq Z
Current Pharmaceutical Design 2022; 0:
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Lv B
Ocular Immunology and Inflammation 2022; 0: 1-11
104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Islam M
Current Pharmaceutical Design 2022; 0:
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Lv Z; Ji N
Ocular Immunology and Inflammation 2022; 0: 1-11
104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Shehzad MT; Ibrar A
Current Pharmaceutical Design 2022; 0:
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Song Z; Wu P
Ocular Immunology and Inflammation 2022; 0: 1-11
104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Khan FA; Marraiki N
Current Pharmaceutical Design 2022; 0:
105096 Molecular Mechanisms of Alu and LINE-1 Interspersed Repetitive Sequences Reveal Diseases of Visual System Dysfunction
Wang X; Mehmood A
Ocular Immunology and Inflammation 2022; 0: 1-11
104789 Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity
Uddin J; Khan A; Al-Harrasi A
Current Pharmaceutical Design 2022; 0:
